References
- Elion GB. Mcchanism of action and selectivity of Acyclovir. Amer J Med. (suppl. July 1982). 7–13.
- Bauer DJ. Acyclovir treatment of expermimental herpetic keratitis in the rabbit eye. Amer J Med. (suppl. July 1982). 311–4.
- Young B, Patterson A, Ravenscroft T. Doubleblind clinical trial of Acyclovir and Adenine Arabinoside in herpetic corneal ulceration. Amer J Med. (suppl. July 1982). 311–4.
- Collum LMT, Logan P, Hillary IB, Ravenscroft T. Acyclovir in herpes keratitis. Amer J Med. (suppl. July 1982). 290–3.
- Neu HC, Fu KP. In vitro antibacterial activity and /3-lactamase stability of SCE-129, a nex cephalosporin. Anlimicrob Agents Chemother. 1979; 15: 646–50.
- Goto S, Ogawa M, Tsuji A et al. SCE 1365, a new cephalosporin: in-vitro antibacterial activities. In Current Chemotherapy and Infectious Disease, Nelson JD, Grassi C Eds. Amer. Soc. Microbiol. Washington DC pp. 264–66, 1980.
- Glockner WM, Peters G, Frisch J, Kindler J. Pharmacokinetics of cefsulodin in patients with severe renal failure. Int J Clin Pharm Res. 1982; II: 255–8.
- Mashimo K, Taguchi T, Nakano Y, Yamamoto T, Yamaguchi N. Pharmacology of SCE-129, a new cephalosporin antibiotic in human volunteers. Current Chemotherapy, Proceedings of the 10th International Congress oj Chemotherapy. 1978; 11: 841–2.
- Durham SR, Wise R. Human pharmacology and tissue levels of CGP 7174/E, a new antipseudomonal cephalosporin. J A ntimicrob Chemother. 1981; 6: 743–7.
- Burmann G, Mertens G, Schult Z, Sack K. Cefsulodin: Tierexperimentelle Untersuchun gen zur Nephrotoxizitat. Infection. 1981; 9: 233–8.
- Tsuchiya K, Kida M, Rondo M, Ono H, Takeuchi M, Nishi T. SCE-963, a new broad spec trum cephalosporin. In vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 1978; 14: 557–68.
- Satake R, Cho R, Taniura M, Oka I, Roo I. Cefotiam concentrations in bile and in the wall of the gallbladder in patients with biliary disease. J Antimicrob Chemother. 1982–10141–5.
- Bergogne-Berezin E, Berthelot G, Rafe H. Study of the diffusion of Cefotiam in the bronchial secretions. Chemotherapy. 1982; 28 • 327–33.
- Wachsmuth ED. Nephrotoxicity of Cefotiam (CGP 1422/E) in rats and rabbits. Arch Toxicol. 1981; 48: 135–56.
- Daschner FD, Hemmer RA, Offerman O, Slanicka J. Pharmacokinetics of Cefotiam in normal humans. Antimicrob Agents Chemother. 1982; 22: 958–60.